21% Growth, 15% Profit Fall—How Inflation Outran Pitti's Volume Gains

Pitti Engineering delivered a quarter that reads two ways at once. The headline ₹578.4 Crore revenue, up 21% year-on-year, is genuine: lamination volumes grew 26%, data center revenue doubled, and order visibility from Cummins, Caterpillar, and railway players remains strong. But the paradox sits in the profit line. Net profit fell 15.5% to ₹33.9 Crore despite that 21% topline growth. The gap is inflation, forex, and execution risk—not demand weakness. This is where the call matters: is this a quarter of temporary headwinds, or a signal that Pitti's operational leverage has broken?

Start with the EBITDA bridge. Absolute EBITDA rose to ₹91 Crore (+13% YoY from ₹80 Cr), which is healthy. But EBITDA margin compressed to 15.8% from 16%+. Management cites a forex loss of ₹4.61 Crore—a direct P&L hit that prior quarters saw near zero. Add fuel, power, and consumables inflation hitting the cost base, and the margin stack deteriorates despite pricing power: lamination volumes up 26%, yet EBITDA margin down. This is the core tension. PAT falls 15.5% because operating leverage is inverted: volume grows, but unit profitability is under pressure from cost inflation and an unhedged foreign exchange exposure that may reverse if the rupee weakens further (a tail risk, not a base case).

The casting shortfall is the red flag. Management held the 17,000-ton target on the call despite H1 delivering only 6,054 tons—36% of the annual goal. When pressed, the MD attributed discrepancy to confusion between machine components (sales) and raw castings (production), a distinction that the data does not clearly resolve. For H2 to bridge a 10,946-ton gap at a run-rate of 3,086 tons per quarter would require a 3.5x acceleration. More likely: full-year casting lands closer to 15,000 tons, a miss on guided 17,000. On margins, management is confident fuel and power costs pass through from January, but the timing depends on customer contract resets—none of which are locked in. The confidence here is hope, not certainty.

The stock sits at ₹851, down 43.7% from its all-time high and below all moving averages (SMA20 ₹1,046.65, SMA50 ₹1,085.93). The RSI reads 19.3—deeply oversold, a territory that typically precedes a reversal or capitulation. Yet foreign institutional investors have been quietly accumulating: FII ownership rose from 0.79% in FY25 Q1 to 1.55% as of Q1 FY27, adding 0.44 percentage points just last quarter. This is a signal. DIIs stable around 20%, promoters locked at 54%. The consensus view seems to be: execution risk is real and priced in; a recovery on capex delivery and margin normalization would offer substantial upside from here. But the stock's drawdown also reflects legitimate concern: casting volume misses, working capital stress (payables spiked to ₹470 Cr from ₹236 Cr), and unproven cost pass-through timing. At current valuations, you are betting on management to deliver the near-term (H2 casting ramp, January margin recovery) to unlock long-term (FY31 capex payoff).

The honest read: This is a company with a credible long-term story (capex, market tailwinds, capex funding confirmed) but material near-term execution risk (casting volume shortfall, margin recovery unproven). The stock's 44% drawdown has compressed valuation, and institutional buying signals belief in a recovery. But recovery hinges on H2 execution, and management has been evasive on unit economics (EBITDA per ton) and casting discrepancy explanations. The margin of safety here is thin. This is a Hold, not a Buy—not because the long-term thesis is weak, but because the next 2–3 quarters will be noisy, and the market may force another repricing if casting ramps fail or pass-through timing slips. For buyers, wait for clarity on H2 casting and Q3 margin realization before adding.